Buscar
Integra Lifesciences Holdings Corp
IARTAñadir a la lista de seguimiento
16.650USD
-0.470-2.75%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
1.29BCap. mercado
PérdidaP/E TTM
Más Datos de Integra Lifesciences Holdings Corp Compañía
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
Información de Integra Lifesciences Holdings Corp
Símbolo de cotizaciónIART
Nombre de la empresaIntegra Lifesciences Holdings Corp
Fecha de salida a bolsaAug 16, 1995
Director ejecutivoPoul (Mojdeh)
Número de empleados4396
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 16
Dirección1100 Campus Road
CiudadPRINCETON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08540
Teléfono16092750500
Sitio Webhttps://www.integralife.com/
Símbolo de cotizaciónIART
Fecha de salida a bolsaAug 16, 1995
Director ejecutivoPoul (Mojdeh)
Ejecutivos de Integra Lifesciences Holdings Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
45.26K
-11.55%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
33.71K
-2.78%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
45.26K
-11.55%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
33.71K
-2.78%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Integra Lifesciences Holdings Corp?
Los cinco principales accionistas de Integra Lifesciences Holdings Corp son: Ms. Mojdeh Poul
¿Cuántas instituciones poseen acciones de Integra Lifesciences Holdings Corp (IART)?
A fecha de 2026Q1, 574 instituciones poseen acciones de Integra Lifesciences Holdings Corp, con un valor de mercado combinado de aproximadamente 82.80M, lo que representa el 106.43% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -14508057.00.
¿Cuál es la mayor fuente de ganancias de Integra Lifesciences Holdings Corp?
El 2026Q1, el segmento empresarial Neurosurgery generó la ganancia más alta para Integra Lifesciences Holdings Corp, ascendiendo a 827.67M y representando el 50.61% de la ganancia total.